文献速递血液透析通路

肾移植后自体动静脉内瘘血栓形成的预测因素

Predictors of Autogenous Arteriovenous Hemodialysis Access Thrombosis after Renal Transplantation.
PubMed 文献 · Ann Vasc Surg · 2017-04-04

单中心回顾性研究纳入2004至2009年145例肾移植时拥有功能良好自体动静脉内瘘的患者,随访中位58个月,59%内瘘保持通畅、29%血栓形成、15%手术关闭;多因素分析显示移植前多次建立内瘘史和活跃吸烟是移植后内瘘血栓形成的独立危险因素。

要点

  • 肾移植后自体动静脉内瘘血栓形成常见,随访期内29%发生血栓。
  • 移植前多次内瘘建立史和活跃吸烟显著增加移植后内瘘血栓风险。
  • 肾移植后仍需监测内瘘,保留通畅以便未来透析需要,除非出现并发症。

核心结论

  • 血栓形成是肾移植后自体动静脉内瘘自然病程的一部分。
  • 移植前多次自体动静脉内瘘建立史和活跃吸烟与内瘘血栓风险显著增加相关。

研究设计与样本

  • 单中心回顾性研究,回顾性分析2004年1月至2009年12月在Clermont-Ferrand大学医院接受肾移植的145例功能良好自体动静脉内瘘患者的前瞻性临床记录。
  • 主要终点为自体动静脉内瘘血栓形成,采用单因素和多因素logistic回归分析识别危险因素。

主要发现

  • 随访结束时81例(59%)内瘘通畅,42例(29%)血栓形成,22例(15%)手术关闭。
  • 单因素分析中移植前多次内瘘史(P=0.03)和活跃吸烟(P=0.02)与移植后内瘘血栓风险显著相关。
  • 多因素logistic回归分析中移植前多次内瘘史(P=0.03)和活跃吸烟(P=0.047)仍与移植后内瘘血栓风险显著相关。

临床怎么用

  • 肾移植后应继续随访自体动静脉内瘘,以便及时发现并处理血栓形成前的并发症。
  • 因肾移植后仍可能需要血液透析,应尽可能保留自体动静脉内瘘的通畅,除非内瘘出现并发症。

局限性

  • 单中心回顾性研究,样本量145例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The fate of autogenous arteriovenous fistula (aAVF) after renal transplantation (RT) remains variable. The aim of this study was to determine the predictors for their thrombosis after RT. METHODS: We conducted a monocentric retrospective review of prospective clinical records of 145 patients with a functional aAVF who had an RT between January 2004 and December 2009 in the University Hospital of Clermont-Ferrand. Our primary end point was the thrombosis of the aAVF. Univariate and multiple logistic regression analyses were used to identify risk factors associated to aAVF thrombosis after RT. RESULTS: There were 105 men (72%) and 40 women (28%), mean age 52 years (range: 18.4-74.7 years). The aAVF was created on average 40 months (range: 2-169) before the RT. The aAVF was distal in 96 cases (66%) and proximal in 49 cases (34%). Nineteen aAVF (13.1%) were complicated and required an endovascular or surgical repair before RT. Forty-nine patients (34%) required multiple aAVF (>2). Mean follow-up from RT was 58 months (range: 1 day-123 months) and from aAVF creation 97 months (range: 5-262 months). At the end of the follow-up, 81 aAVFs (59%) were patent, 42 (29%) were thrombosed, and 22 (15%) were surgically closed. Patients that had multiple fistulas before RT and active smokers were significantly at risk to thrombose their aAVF after the RT in univariate (P = 0.03 and P = 0.02, respectively) and multiple logistic regression analyses (P = 0.03 and P = 0.047, respectively). CONCLUSIONS: Thrombosis is a part of the natural history of the aAVF after RT. A history of multiple aAVF creations before RT and active smoking were associated to significant increased risk for fistula thrombosis. Because hemodialysis may be needed after RT, the aAVF patency should be preserved, excepted when the aAVF resulted in complications. Follow-up of the aAVF after RT is important to detect and treat complications before thrombosis occurs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ben Ahmed S, Hadj-Abdelkader M, Benezit M, et al. Predictors of Autogenous Arteriovenous Hemodialysis Access Thrombosis after Renal Transplantation. Ann Vasc Surg. 2017. PMID: 28389288. doi:10.1016/j.avsg.2017.01.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。